We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
-4.5%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$33.8B
AUM Growth
-$562M
(-1.6%)
Cap. Flow
+$961M
Cap. Flow
% of AUM
2.84%
Top 10 Holdings %
Top 10 Hldgs %
23.33%
Holding
1,460
New
97
Increased
616
Reduced
423
Closed
88
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$150M |
| 2 |
L3Harris
LHX
|
+$88.5M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$79M |
| 4 |
PNC Financial Services
PNC
|
+$76.2M |
| 5 |
Johnson & Johnson
JNJ
|
+$70.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$87.1M |
| 2 |
Linde
LIN
|
+$54.9M |
| 3 |
Amazon
AMZN
|
+$46.7M |
| 4 |
Meta Platforms (Facebook)
META
|
+$43.7M |
| 5 |
Encompass Health
EHC
|
+$39.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.13% |
| 2 | Healthcare | 19.65% |
| 3 | Financials | 10.78% |
| 4 | Industrials | 9.28% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Vistra
VST
$48.6B
| $487K | ﹤0.01% |
22,955
-58,148
| -72% | -$1.41M |
|
1052
Arbutus Biopharma
ABUS
$923M
| $485K | ﹤0.01% |
250,000
| – | – |
|
1053
Sibanye-Stillwater
SBSW
$7.51B
| $483K | ﹤0.01% |
51,950
+26,000
| +100% | +$247K |
|
|
LUXE
1054
LuxExperience B.V.
LUXE
$1.11B
| $482K | ﹤0.01% |
42,270
+1,015
| +2% | +$13K |
|
1055
Amphastar Pharmaceuticals
AMPH
$869M
| $477K | ﹤0.01% |
16,800
| – | – |
|
1056
Casey's General Stores
CASY
$30.7B
| $476K | ﹤0.01% |
2,339
+1,180
| +102% | +$244K |
|
1057
Novavax
NVAX
$1.31B
| $476K | ﹤0.01% |
25,850
| – | – |
|
1058
UMB Financial
UMBF
$11.2B
| $476K | ﹤0.01% |
+5,648
| New | +$511K |
|
|
SWTX
1059
DELISTED
SpringWorks Therapeutics
SWTX
| $473K | ﹤0.01% |
17,250
| – | – |
|
1060
Rapid7
RPD
$902M
| $472K | ﹤0.01% |
11,000
| – | – |
|
1061
RLI Corp
RLI
$5.87B
| $460K | ﹤0.01% |
+8,944
| New | +$500K |
|
1062
Revolution Medicines
RVMD
$44.1B
| $459K | ﹤0.01% |
23,800
| – | – |
|
|
INBX
1063
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $452K | ﹤0.01% |
26,400
| – | – |
|
1064
Teradata
TDC
$2.5B
| $449K | ﹤0.01% |
14,558
-823
| -5% | -$28.8K |
|
1065
Icon
ICLR
$12.8B
| $446K | ﹤0.01% |
2,463
-58
| -2% | -$12.6K |
|
1066
ABM Industries
ABM
$2.83B
| $445K | ﹤0.01% |
+11,716
| New | +$513K |
|
1067
ICL Group
ICL
$6.89B
| $444K | ﹤0.01% |
54,105
+1,237
| +2% | +$11.6K |
|
1068
Texas Pacific Land
TPL
$25.2B
| $444K | ﹤0.01% |
+2,286
| New | +$440K |
|
1069
FuelCell Energy
FCEL
$1.54B
| $442K | ﹤0.01% |
+4,293
| New | +$514K |
|
|
TCN
1070
DELISTED
Tricon Residential Inc.
TCN
| $440K | ﹤0.01% |
52,915
-3,218
| -6% | -$34K |
|
1071
Liberty Global Class A
LBTYA
$3.48B
| $434K | ﹤0.01% |
27,559
-31,621
| -53% | -$636K |
|
1072
Shinhan Financial Group
SHG
$34.3B
| $434K | ﹤0.01% |
18,773
+6,500
| +53% | +$172K |
|
1073
Cleveland-Cliffs
CLF
$7.08B
| $433K | ﹤0.01% |
31,586
+1,786
| +6% | +$29.7K |
|
1074
Kinross Gold
KGC
$32.3B
| $424K | ﹤0.01% |
118,064
+4,164
| +4% | +$14.2K |
|
1075
Radware
RDWR
$1.2B
| $424K | ﹤0.01% |
19,500
| – | – |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q3 2022 Portfolio in Review
As of Q3 2022, DekaBank Deutsche Girozentrale held 1,460 positions worth $33.8B, down 1.6% from $34.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
DekaBank Deutsche Girozentrale's Q3 2022 filing shows 97 new, 616 increased, 423 reduced and 88 closed positions. Its largest new stake was Energy Recovery: 388,416 shares worth $8.58M. The largest sale was Lam Research, an estimated $87.1M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- DekaBank Deutsche Girozentrale's largest Q3 2022 buy was Energy Recovery: 388,416 shares worth $8.58M.
- DekaBank Deutsche Girozentrale added most to NVIDIA in Q3 2022, an estimated $150M increase.
- DekaBank Deutsche Girozentrale's biggest Q3 2022 reduction was Lam Research, cutting an estimated $87.1M.
- DekaBank Deutsche Girozentrale fully exited SPX Corp in Q3 2022, selling an estimated $11.9M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 23% of its $33.8B portfolio in Q3 2022.
- DekaBank Deutsche Girozentrale opened 97 new positions and closed 88 in Q3 2022.
- DekaBank Deutsche Girozentrale's portfolio value fell 1.6% quarter-over-quarter to $33.8B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2022, filed 2 Nov 2022.